China-Biotics, Inc. Announces Appointment of New Transfer Agent Effective August 15, 2008

Tuesday, July 15, 2008 General News
Email Print This Page Comment bookmark
Font : A-A+

SHANGHAI, China, July 15 China-Biotics,Inc. (OTC Bulletin Board: CHBT) ("China-Biotics," "the Company"), a leadingChinese firm specializing in the manufacture, research, development, marketingand distribution of probiotics products, today announced the appointment ofAmerican Stock Transfer & Trust Company ("AST") as its new transfer agent andregistrar, effective August 15, 2008. AST, headquartered in New York, NewYork, replaces the Company's former transfer agent and registrar, AmericanRegistrar & Transfer Company.

Consistently ranked #1 in the prestigious Group Five survey, AST haspioneered a unique, customer-driven approach to the provision of comprehensivetransfer agency services. Founded in 1971, AST has grown to be the largestindependent stock transfer agent in the United States.

Stockholders seeking information regarding stock transfer, lostcertificates, and address changes may contact AST as follows:

About China-Biotics, Inc.

Headquartered in Shanghai, China-Biotics, Inc. ("China-Biotics", "theCompany") was founded in 1999 and is one of China's largest suppliers ofprobiotics. Probiotics are beneficial live bacteria used as dietarysupplements and food additives to improve intestinal health and digestion.The Company's product portfolio contains live microbials made with proprietarytechnology. Currently, these products are sold over-the-counter under the"Shining" brand through large distributors to more than 1,000 pharmacies and100 supermarkets in Shanghai, Jiangsu and Zhejiang. Shining is one of the mostrecognized brands in Shanghai. China-Biotics plans to expand its retail salesto other major cities in China and is launching 300 Shining brand logisticcenters in these cities. The Company's flagship product, "Shining Essence",has been a profit driver since its launch in April 2001. There is asignificant demand for probiotics for use in the bulk additive market, whichis currently met by imports. China-Biotics is building a new plant which willincrease its production capacity manifolds to capture this market. For moreinformation, please visit .

Safe Harbor Statement Under the Private Securities Litigation Reform Actof 1995: Any statements set forth above that are not historical facts areforward-looking statements that involve risks and uncertainties that couldcause actual results to differ materially from those in the forward-lookingstatements. Such factors include, but are not limited to, the Company'sability to market existing and new products, ability to access capital forexpansion, changes from anticipated levels of sales, future national orregional economic and competitive conditions, changes in relationships withcustomers, dependence on its flagship product profits and other factorsdetailed from time to time in the Company's filings with the United StatesSecurities and Exchange Commission and other regulatory authorities. TheCompany undertakes no obligation to publicly update or revise anyforward-looking statements, whether as a result of new information, futureevents or otherwise.For General Information American Stock Transfer & Trust Company 59 Maiden Lane New York, NY 10038 Stockholder Toll-Free line: 1-800-937-5449 World Wide: 1-718-921-8200 Fax: 1-718-236-2641

SOURCE China-Biotics, Inc.

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store